The role of protein kinase C (PKC) in inflammation, mitogenesis, and differentiation has been deduced in part through the use of a variety of PKC inhibitors. Two widely used inhibitors are the structurally related compounds GF109203X and Ro-31-8220, both of which potently inhibit PKC activity and are believed to be highly selective. While using GF109203X and Ro-31-8220 to address the role of PKC in immediate early gene expression, we observed striking differential effects by each of these two compounds. Growth factors induce the expression of the immediate early gene products MAP kinase phosphatase-1 (MKP-1), c-Fos and c-Jun. Ro-31-8220 inhibits growth factor-stimulated expression of MKP-1 and c-Fos but strongly stimulated c-Jun expression, even in the absence of growth factors. GF109203X displays none of these properties.These data suggest that Ro-31-8220 may have other pharmacological actions in addition to PKC inhibition. Indeed, Ro-31-8220 strongly stimulates the stress-activated protein kinase, JNK1. Furthermore, Ro-31-8220 apparently activates JNK in a PKC-independent manner. Neither the down-regulation of PKC by phorbol esters nor the inhibition of PKC by GF109203X affected the ability of Ro-31-8220 to activate JNK1. These data suggest that, in addition to potently inhibiting PKC, Ro-31-8220 exhibits novel pharmacological properties which are independent of its ability to inhibit PKC.
Protein kinase C (PKC)1 is a large and diverse family of protein kinases, whose members are differentially regulated by calcium, phorbol esters, diglycerides, and phosphatidic acid (for a review, see Ref. 1). The various PKC isozymes play important signaling roles in cellular growth, differentiation, and homeostasis. The reported cellular roles of PKC have been identified largely through the use of PKC activators and inhibitors. The bisindolemaleimide class of compounds are staurosporine analogs which by all reports are specific for PKC (2, 3). Two widely used bisindolemaleimides, GF109203X and Ro-31-8220, differ by a single functional group, and although their isozyme specificity varies slightly, they are both potent and selective PKC inhibitors.In addition to cellular responses that may be attributed directly to PKC, PKC signaling pathways likely also contribute to cellular signaling through cross-talk mechanisms with other signaling cascades. Multiple lines of evidence indicate a role for PKC in regulating the ERK and JNK cascades which regulate transcription factors in response to external stimuli. The ERK cascade, a growth factor-stimulated signaling cascade is regulated by the Ras and Raf protooncogenes which activate MEK which in turn activates ERK1 and ERK2 (4, 5). ERK1 and -2 accumulate in the nucleus and phosphorylate and transactivate the transcription factor TCF/Elk-1 (6). A parallel signaling pathway activated by cellular stresses such as uv light and translational inhibitors leads to the activation of MEKK1, SEK, and in turn JNK1 and JNK2 (7, 8). The major role of the JNK signaling pathway is believed to be the...